4sight Health December 5, 2024
David Burda

Grab a big tub of (unbuttered and unsalted) popcorn and watch the upcoming political battle over Medicare and Medicaid coverage of new weight-loss drugs to treat obesity as a disease. We handicapped the fight in the new episode of the 4sight...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Insurance, Medicaid, Medicare, Pharma / Biotech, Trends
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
Stakeholder Management and Interoperability of Biosimilars
Anne Wojcicki has a new offer to take 23andMe private, this time for $74.7 million
Pharma Pulse 2/21/25: RWE in Medical Research and Drug Development, Inhaled Antibody Therapy for RSV & more
FDA approves first rapid-acting insulin biosimilar for diabetes

Share This Article